🔎 Trials Near Me

Home › Heart Failure › Oregon

Heart Failure clinical trials in Oregon

17 studies for Heart Failure are looking for participants at sites in Oregon.

Cities in Oregon

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

  • Providence St. Vincent Medical Center, Portland
Recruiting
Ages 18 to 80 · All sexes · Updated Nov 12, 2026 · NCT06965504

Left vs Left Randomized Clinical Trial

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05650658

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06526195

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Oregon Health and Science University, Portland
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT06736574

CCM OPEN HF Registry

  • Providence St. Vincent Medical Center, Portland
  • Legacy Medical Group Cardiology, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07112924

Cardiogenic Shock Working Group Registry

  • Providence St. Vincent Heart Clinic, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT04682483

Assessment of CCM in HF With Higher Ejection Fraction

  • Providence Heart & Vascular, Portland
Recruiting
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT05064709

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06461962

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Portland
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 13, 2026 · NCT06307652

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

  • VA Portland Health Care System, Portland, OR, Portland
Recruiting
Ages 60 and older · All sexes · Updated Oct 7, 2026 · NCT05996328

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

  • Research Site, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07690436

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Oregon Health & Science University, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • Providence St. Vincent's - Portland, Portland
  • Oregon Health Science Portland, Portland
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Oregon Health & Science University (OHSU), Portland
  • Providence Heart Institute, Portland
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Oregon Health and Science University, Portland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

  • Providence Heart Institute, Portland
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated May 22, 2024 · NCT06425848

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.